~~<i id='0C18B967AA'><strike id='0C18B967AA'><tt id='0C18B967AA'><pre id='0C18B967AA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：leisure time 2025-10-02 13:40:56 - browse：54711

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Gene editing the human germline: What are the risks?

entertainment

hotspot

knowledge

focus

Wikipedia

MatthewMead/AP“Feedacold,starveafever”isanadagethathasbeenaroundforcenturies.Nowanewstudyinmicefinds

WSS

With heat waves through August, officials warn of health risks

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Doctors push to include dialysis machines in emergency stockpile

With heat waves through August, officials warn of health risks

St. Louis police protesters begin picking up checks in $4.9 million settlement

Kansas bar where gunfire wounded 9 last month closes permanently

focus

leisure time

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

At least 13 dead in Texas as scorching temps continue

Colonoscopy prep: Liquid

Bright Health sells Medicare Advantage business to Molina

Physicians and social media: If you see something, say something?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Failure, not just success, should guide future doctors

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Kansas bar where gunfire wounded 9 last month closes permanently

hotspot

With heat waves through August, officials warn of health risks

Neuroscience’s long legacy of racism

Future doctors should be trained to promote social change

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Intermittent fasting comes with a heart risk? Not so fast

Stop the failed accountable care organization experiment

knowledge

focus

focus

Wikipedia